Publication:
Solid phase synthesis of novel asymmetric hydrophilic head cholesterol-based cationic lipids with potential DNA delivery

dc.contributor.authorRadchatawedchakoon W.
dc.contributor.authorWatanapokasin R.
dc.contributor.authorKrajarng A.
dc.contributor.authorYingyongnarongkul B.-E.
dc.date.accessioned2021-04-05T03:37:11Z
dc.date.available2021-04-05T03:37:11Z
dc.date.issued2010
dc.date.issuedBE2553
dc.description.abstractTwenty-four asymmetric divalent head group cholesterol-based cationic lipids were designed and synthesized by parallel solid phase chemistry. These asymmetric head groups composed of amino functionality together with trimethylamino, di(2-hydroxyethyl)amino or guanidinyl groups. Spacers between cationic heads and linker were both equal and unequal in length. These lipids were subjected to evaluation for DNA binding affinities by gel retardation assay and were screened for their transfection efficiency on HEK293 cells. Cationic lipids with equal chain length exhibited high transfection efficiency when polar part contained asymmetric polar heads. In contrast, lipids with unequal chain length exhibited high transfection efficiency when polar part contained symmetric heads. According to the optimal formulation, seven lipids exhibited higher transfection efficiency than the commercially available transfection agents, Effectene™, DOTAP and DC-Chol, to deliver DNA into PC3 human prostate adenocarcinoma cells. 3β-[N-(N′-Guanidinyl)-2′-aminoethyl)-N-(2-aminoethyl)ca rbamoyl] cholesterol (5) bearing amino and guanidinyl polar heads exhibited highest transfection efficiency with minimal toxicity. The morphology of active liposomes was observed by transmission electron microscopy (TEM) and size of liposomes were around 200-700 nm. © 2009 Elsevier Ltd. All rights reserved.
dc.format.mimetypeapplication/pdf
dc.identifier.citationBioorganic and Medicinal Chemistry. Vol 18, No.1 (2010), p.330-342
dc.identifier.doi10.1016/j.bmc.2009.10.057
dc.identifier.issn9680896
dc.identifier.other2-s2.0-72149112492
dc.identifier.urihttps://hdl.handle.net/20.500.14740/7685
dc.rights.holderมหาวิทยาลัยศรีนครินทรวิโรฒ
dc.subject.other3b [n [n',n' di(2'' hydroxyethyl) 2' aminoethyl] n [n glycine[n (2 aminoethyl)amide]]carbamoyl]cholesterol
dc.subject.other3beta [n (2' aminoethyl) n [n glycine[n (2 aminoethyl)amide]]carbamoyl]cholesterol
dc.subject.other3beta [n (2' aminoethyl) n [n glycine[n (3 aminopropyl) amide]]carbamoyl]cholesterol
dc.subject.other3beta [n (3' aminopropyl) n [n glycine[n (2 aminoethyl) amide]]carbamoyl]cholesterol
dc.subject.other3beta [n (3' aminopropyl) n [n glycine[n (3 aminopropyl) amide]]carbamoyl]cholesterol
dc.subject.other3beta [n (n' guanidinyl 2' aminoethyl) n [n glycine[n (2 aminoethyl)amide]]carbamoyl]cholesterol
dc.subject.other3beta [n (n' guanidinyl 2' aminoethyl) n [n glycine[n (3 aminopropyl)amide]]carbamoyl]cholesterol
dc.subject.other3beta [n (n' guanidinyl 3' aminopropyl) n [n glycine [n (3 aminopropyl)amide]]carbamoyl]cholesterol
dc.subject.other3beta [n (n' guanidinyl 3' aminopropyl) n [n glycine[n (2 aminoethyl)amide]] carbamoyl]cholesterol
dc.subject.other3beta [n (n' guanidinyl) 2' aminoethyl n (2 aminoethyl)carbamoyl]cholesterol
dc.subject.other3beta [n (n',n' di(2'' hydroxyethyl) 3' aminopropyl) n (3 aminopropyl)carbamoyl]cholesterol
dc.subject.other3beta [n [(n' guanidinyl) 2' aminoethyl] n (2 aminoethyl) carbamoyl]cholesterol
dc.subject.other3beta [n [(n' guanidinyl) 3' aminopropyl] n (3 aminoproyl)carbamoyl]cholesterol
dc.subject.other3beta [n [(n',n',n' trimethyl) 2' aminoethyl] n (2 amino ethyl)carbamoyl]cholesterol
dc.subject.other3beta [n [(n',n',n' trimethyl) 2' aminoethyl] n [n glycine[n (2 aminoethyl)amide]]carbamoyl]cholesterol
dc.subject.other3beta [n [(n',n',n' trimethyl) 2' aminoethyl] n [n glycine[n (3 aminopropyl)amide]]carbamoyl]cholesterol
dc.subject.other3beta [n [(n',n',n' trimethyl) 3' aminopropyl] n (3 aminopropyl)carbamoyl]cholesterol
dc.subject.other3beta [n [(n',n',n' trimethyl) 3' aminopropyl] n [n glycine [n (2 aminoethyl)amide]]carbamoyl]cholesterol
dc.subject.other3beta [n [(n',n',n' trimethyl) 3' aminopropyl] n [n glycine [n (3 aminopropyl)amide]]carbamoyl] cholesterol
dc.subject.other3beta [n [n',n' di(2'' hydroxyethyl) 2' aminoethyl] n (2 aminoethyl)carbamoyl]cholesterol
dc.subject.other3beta [n [n',n' di(2'' hydroxyethyl) 2' aminoethyl] n [n glycine[n (3 aminopropyl)amide]]carbamoyl]cholesterol
dc.subject.other3beta [n [n',n' di(2'' hydroxyethyl) 3' aminopropyl] n [n glycine[n (2 aminoethyl)amide]]carbamoyl]cholesterol
dc.subject.other3beta [n [n',n' di(2'' hydroxyethyl) 3' aminopropyl] n [n glycine[n (3 aminopropyl)amide]]carbamoyl]cholesterol
dc.subject.other3beta [n,n (2,2' diaminoethyl)carbamoyl]cholesterol
dc.subject.other3beta [n,n (3,3' diaminopropyl)carbamoyl]cholesterol
dc.subject.otherCholesterol derivative
dc.subject.otherUnclassified drug
dc.subject.otherArticle
dc.subject.otherBinding affinity
dc.subject.otherCarbon nuclear magnetic resonance
dc.subject.otherControlled study
dc.subject.otherDNA binding
dc.subject.otherDNA transfection
dc.subject.otherDrug design
dc.subject.otherDrug structure
dc.subject.otherDrug synthesis
dc.subject.otherGene targeting
dc.subject.otherHuman
dc.subject.otherHuman cell
dc.subject.otherProstate adenocarcinoma
dc.subject.otherProton nuclear magnetic resonance
dc.subject.otherSolid phase synthesis
dc.subject.otherTransmission electron microscopy
dc.subject.otherBinding Sites
dc.subject.otherCations
dc.subject.otherCell Line
dc.subject.otherCell Line, Tumor
dc.subject.otherCholesterol
dc.subject.otherDNA
dc.subject.otherHumans
dc.subject.otherLipids
dc.subject.otherLiposomes
dc.subject.otherPhosphatidylethanolamines
dc.subject.otherSerum
dc.subject.otherTransfection
dc.titleSolid phase synthesis of novel asymmetric hydrophilic head cholesterol-based cationic lipids with potential DNA delivery
dc.typeArticle
dspace.entity.typePublication
swu.datasource.scopushttps://www.scopus.com/inward/record.uri?eid=2-s2.0-72149112492&doi=10.1016%2fj.bmc.2009.10.057&partnerID=40&md5=f1a09ff986602cf0a9e30304b768f92e

Files